Literature DB >> 10431659

Lipoprotein(a): intrigues and insights.

H H Hobbs1, A L White.   

Abstract

Lipoprotein(a) is an atherogenic, cholesterol ester-rich lipoprotein of unknown physiological function. The unusual species distribution of lipoprotein(a) and the extreme polymorphic nature of its distinguishing apolipoprotein component, apolipoprotein(a), have provided unique challenges for the investigation of its biochemistry, genetics, metabolism and atherogenicity. Some fundamental questions regarding this enigmatic lipoprotein have escaped elucidation, as will be highlighted in this review.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10431659     DOI： 10.1097/00041433-199906000-00005

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN： 0957-9672            Impact factor:   4.776


  33 in total

1.  Clinical implications of elevated lipoprotein(a).

Authors:  A von Eckardstein; G Assmann
Journal:  Curr Atheroscler Rep       Date:  2001-07       Impact factor: 5.113

Review 2.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

3.  Modification of lipoprotein(a) by natural dicarbonyls induced their following free radical peroxidation.

Authors:  V Z Lankin; O I Afanasieva; G G Konovalova; E A Utkina; O A Dmitrieva; A K Tikhaze; E M Kumskova; S N Pokrovsky
Journal:  Dokl Biochem Biophys       Date:  2012-01-06       Impact factor: 0.788

Review 4.  Lipoprotein apheresis for the treatment of elevated circulating levels of lipoprotein(a): a critical literature review.

Authors:  Massimo Franchini; Enrico Capuzzo; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-12-22       Impact factor: 3.443

5.  Relook at lipoprotein (A): independent risk factor of coronary artery disease in north Indian population.

Authors:  Jamal Yusuf; Neeraj Yadav; Saibal Mukhopadhyay; Abhishek Goyal; Vimal Mehta; Vijay Trehan; Sanjay Tyagi
Journal:  Indian Heart J       Date:  2014-04-21

Review 6.  Novel metabolic biomarkers of cardiovascular disease.

Authors:  Majken K Jensen; Monica L Bertoia; Leah E Cahill; Isha Agarwal; Eric B Rimm; Kenneth J Mukamal
Journal:  Nat Rev Endocrinol       Date:  2014-09-02       Impact factor: 43.330

Review 7.  Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications.

Authors:  Angelo M Scanu
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

8.  Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia.

Authors:  S van Wissen; T J Smilde; M D Trip; Th de Boo; J J P Kastelein; A F H Stalenhoef
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

9.  Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).

Authors:  Margaret R Diffenderfer; Stefania Lamon-Fava; Santica M Marcovina; P Hugh R Barrett; Julian Lel; Gregory G Dolnikowski; Lars Berglund; Ernst J Schaefer
Journal:  Metabolism       Date:  2015-11-06       Impact factor: 8.694

Review 10.  Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

Authors:  Sebhat Erqou; Stephen Kaptoge; Philip L Perry; Emanuele Di Angelantonio; Alexander Thompson; Ian R White; Santica M Marcovina; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-07-22       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.